FDA Inspection 1102216 — Greer Laboratories, Inc.

Greer Laboratories, Inc. — FEI 1011574

The FDA completed an inspection of Greer Laboratories, Inc. on Sep 11, 2019 in Lenoir, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 11, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Lenoir, NC (United States)

Citations

IDCFRDescription
142121 CFR 211.42(c)(10)Aseptic Processing Area
1597321 CFR 111.120(c)Quality control operations - material review, disposition decision
359421 CFR 211.110(d)Rejected in-process materials not quarantined
601121 CFR 123.8(a)(3)(ii)Corrective action record review adequacy

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.